| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/02/1995 | WO1995005846A1 Neural regeneration using human bone morphogenetic proteins |
| 03/02/1995 | WO1995005845A1 Pharmaceutical formulations of nerve growth factor |
| 03/02/1995 | WO1995005813A1 COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID |
| 03/02/1995 | WO1995005812A1 Anthelmintic formulations |
| 03/02/1995 | WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/02/1995 | WO1995005807A1 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient |
| 03/02/1995 | WO1995005805A1 Process for conditioning substances |
| 03/02/1995 | WO1994025025A3 Systems for controlled release of pilocarpine |
| 03/02/1995 | CA2170504A1 Compositions and methods for the administration of u-aminolevulinic acid |
| 03/02/1995 | CA2169840A1 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient |
| 03/02/1995 | CA2169828A1 Transfection process |
| 03/02/1995 | CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/01/1995 | EP0640647A2 Ionically crosslinked glycosaminoglycan gels for soft tissue augmentation and drug delivery |
| 03/01/1995 | EP0640622A1 Polysaccharide derivative and drug carrier |
| 03/01/1995 | EP0640352A1 Preparation of a skin surface for a surgical procedure |
| 03/01/1995 | EP0640350A2 Ceramic particles and their preparation |
| 03/01/1995 | EP0640347A1 Oral vaccine |
| 03/01/1995 | EP0640346A1 Uses of sulphated sugars against inflammation |
| 03/01/1995 | EP0640344A1 Pharmaceutical composition in liquid dosage form containing ursodeoxycholic acid |
| 03/01/1995 | EP0640337A2 Controlled release-initiation and controlled release-rate pharmaceutical composition |
| 03/01/1995 | EP0640336A1 Parenteral sustained releasable preparations comprising polyglycerol diesters |
| 03/01/1995 | EP0640130A1 Chimeric multivalent protein analogues and methods of use thereof |
| 03/01/1995 | EP0640094A1 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 03/01/1995 | EP0639986A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| 03/01/1995 | EP0639984A1 Lyophilized somatotropin formulations |
| 03/01/1995 | EP0390911B1 Low-melting moldable pharmaceutical excipient and its use with pharmaceutical compositions |
| 03/01/1995 | CN1099262A Controlled release formulation |
| 03/01/1995 | CA2131116A1 Composition for rectal administration |
| 02/28/1995 | US5393792 High dosage topical forms of collagenase |
| 02/28/1995 | US5393765 Pharmaceutical compositions with constant erosion volume for zero order controlled release |
| 02/28/1995 | US5393738 Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration |
| 02/28/1995 | US5393737 Cytotoxic drug conjugates for treatment of neoplastic diseases |
| 02/28/1995 | US5393535 Water in oil emulsion |
| 02/28/1995 | US5393530 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated |
| 02/28/1995 | US5393333 Film-forming product for coating solid forms, process for its manufacture and products coated with this film-forming product |
| 02/28/1995 | CA2130015A1 Preparation of a skin surface for a surgical procedure |
| 02/27/1995 | CA2130868A1 Sustained releasable parenteral pharmaceutical preparations and method of producing the same |
| 02/27/1995 | CA2130295A1 Ionically crosslinked glycosaminoglycan gels for soft tissue augmentation and drug delivery |
| 02/26/1995 | CA2130595A1 Controlled release-initiation and controlled release-rate pharmaceutical composition |
| 02/23/1995 | WO1995005412A1 Cosmetic melanins |
| 02/23/1995 | WO1995005402A1 Aqueous copolymer dispersions |
| 02/23/1995 | WO1995005397A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | WO1995005200A1 Drug delivery agents incorporating mitomycin |
| 02/23/1995 | WO1995005199A1 Pharmaceutical preparation and a process for making same |
| 02/23/1995 | WO1995005198A1 Localanaesthetic preparation |
| 02/23/1995 | WO1995005197A1 THE USE OF 2-HYDROXYPROPYL-β-CYCLODEXTRIN (CDEX) FOR PREPARING AN OPIOID ANALGESIC PREPARATION FOR INTRAMUSCULAR OR SUBCUTANEOUS ADMINISTRATION |
| 02/23/1995 | WO1995005188A1 Erection-inducing methods and compositions |
| 02/23/1995 | WO1995005187A1 Hepatoselective pharmaceutical actives |
| 02/23/1995 | WO1995005165A1 Hydrolyzed gelatin as a flavor enhancer in a chewable tablet |
| 02/23/1995 | WO1995005137A1 Transdermal delivery system using a combination of permeation enhancers |
| 02/23/1995 | DE4327923A1 Polyvinyl alcohol gel, and process for the preparation thereof |
| 02/23/1995 | CA2402590A1 Phospate-binding polymers for oral administration |
| 02/23/1995 | CA2169371A1 Hydrolyzed gelatin as a flavor enhancer in a chewable tablet |
| 02/23/1995 | CA2169178A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | CA2168947A1 Aqueous copolymer dispersions |
| 02/22/1995 | EP0639582A2 Polynucleotide assay reagent and method |
| 02/22/1995 | EP0639380A1 Cyclodextrin inclusion product of taxol, process for producing the same, and its use |
| 02/22/1995 | EP0639376A1 Liquid composition containing amide derivative |
| 02/22/1995 | EP0639375A1 A bile duct deterging composition |
| 02/22/1995 | EP0639372A1 Device for distributing a therapeutic or cosmetic substance, where the inert carrier is a volatile polydiorganosiloxane, and composition for use in this device |
| 02/22/1995 | EP0639202A1 Stable polypeptide composition |
| 02/22/1995 | EP0639083A1 Complexing agents and targeting immunoreagents |
| 02/22/1995 | EP0639071A1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil |
| 02/22/1995 | EP0639070A1 Use of borate-polyol complexes in ophthalmic compositions |
| 02/22/1995 | EP0619732A4 Biodegradable polymers for cell transplantation. |
| 02/22/1995 | EP0437563B1 Biologically active drug polymer derivatives |
| 02/22/1995 | CN1098907A Dry mix formulation for bisphosphonic acids |
| 02/21/1995 | US5391785 Partially protected alcohols, used to make phosphoramidites for modifying oligonucleotides |
| 02/21/1995 | US5391723 Oligonucleotide conjugates |
| 02/21/1995 | US5391642 Reacting aspartic acid with polyamine, then salt formation with hydroxide |
| 02/21/1995 | US5391548 Transdermal flux enhancing compositions to treat hypertension, diabetes and angina pectoris |
| 02/21/1995 | US5391377 Biphasic release formations for lipophilic acids |
| 02/21/1995 | US5391376 Method for preventing and treating cachexia |
| 02/21/1995 | US5391375 Impermeable cover layer, pressure sensitive adhesive reservoir layer containing basic polymer, softener, physostigmine solution in acid solvent |
| 02/21/1995 | US5391367 Antifungal nail solution |
| 02/21/1995 | CA1334513C Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 02/17/1995 | CA2130132A1 Bile duct deterging composition and a method for deterging the bile duct |
| 02/16/1995 | WO1995004592A1 Concentrated aqueous compositions of alkylpolyglycosides, and applications thereof |
| 02/16/1995 | WO1995004551A1 Percutaneously absorbable preparation |
| 02/16/1995 | WO1995004550A1 Antiseptic |
| 02/16/1995 | WO1995004528A2 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE |
| 02/16/1995 | WO1995004527A1 Gelatin capsules containing a highly concentrated acetaminophen solution |
| 02/16/1995 | WO1995001167A3 Incorporating poly-n-vinyl amide in a transdermal system |
| 02/16/1995 | DE4326777A1 Physiologically tolerated and physiologically degradable polymer-based carbohydrate receptor blocker, a process for its preparation and its use |
| 02/16/1995 | CA2169172A1 Percutaneously absorbable preparation |
| 02/15/1995 | EP0638589A1 Inuline derivatives, process for their production and uses |
| 02/15/1995 | EP0638318A2 Compositions for increasing the image contrast in diagnostic investigations of the digestive tract |
| 02/15/1995 | EP0638310A1 Pharmaceutical compositions containing ifetroban |
| 02/15/1995 | EP0638119A1 Chimeric receptor genes and cells transformed therewith |
| 02/15/1995 | EP0638104A1 Undecylenic acid derivatives with hydrophilic molecules and utilizations in cosmetics or in pharmacy |
| 02/15/1995 | EP0638086A1 Benzoate esters of alkoxylated methyl glucosides |
| 02/15/1995 | EP0638085A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 02/15/1995 | EP0637957A1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases. |
| 02/15/1995 | EP0637933A1 Method and kit for imaging and treating organs and tissues |
| 02/15/1995 | EP0627900A4 Use of injectable biomaterials for the repair and augmentation of the anal sphincters. |
| 02/15/1995 | EP0542926B1 Use of interfacially-polymerized membranes in delivery devices |
| 02/15/1995 | EP0389570B1 High integrity liposomes and method of preration and use |
| 02/14/1995 | US5389681 Parenteral solutions for diclofenac salts |
| 02/14/1995 | US5389677 Method of treating wrinkles using glycalic acid |
| 02/14/1995 | US5389385 Administering water soluble elementary iodine |